Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 26 citing Bower: Brief communication: rituximab in HIV-associated multicentric Castleman disease. (0.07 sec) 

Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma-Associated Herpesvirus …


RJ Sullivan, L Pantanowitz, C Casper, J … - Clinical Infectious Diseases, 2008 - UChicago Press
Featured in Reuters "Anal HPV infection clears quickly in women" March 16, 2009
Duration and Clearance of Anal Human Papillomavirus (HPV) Infection among Women:
The Hawaii HPV Cohort Study Yurii B. Shvetsov, Brenda Y. Hernandez, ...
Cited by 11 - Related articles - All 5 versions

HIV-associated multicentric Castleman's disease


J Stebbing, L Pantanowitz, F Dayyani, RJ … - American Journal of Hematology, 2008 - interscience.wiley.com
Multicentric Castleman's disease (MCD), a relatively rare lymphoproliferative
disorder that presents with heterogenous symptoms including fevers, anemia, and
multifocal lymphadenopathy, is today most commonly observed in individuals ...
Cited by 10 - Related articles - BL Direct - All 2 versions

Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals …


KN Naresh, AJ Rice, M Bower - The American Journal of Surgical Pathology, 2008 - journals.lww.com
Multicentric Castleman disease (MCD), a lymphoproliferative disorder and Kaposi
sarcoma (KS), a vascular tumor, both occur at a higher frequency among patients
with human immunodeficiency virus (HIV) infection. Human herpes virus 8 ...
Cited by 5 - Related articles - All 2 versions

Pathology of rituximab-induced Kaposi sarcoma flare


L Pantanowitz, K Früh, S Marconi, AV Moses … - BMC Clinical Pathology, 2008 - biomedcentral.com
© 2008 Pantanowitz et al; licensee BioMed Central Ltd. This is an Open Access
article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted ...
Cited by 2 - Related articles - Cached - All 7 versions

Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) …


A Fragasso, C Mannarella, A Ciancio, A … - Leukemia & Lymphoma, 2008 - informahealthcare.com
A 78-year-old man was hospitalised in our Medical Unit in September 2006 because
of fatigue, dyspnoea, weight loss, itching and fever for 1 month. The physical
examination revealed paleness, mild hepatomegaly and splenomegaly (4 cm ...
Cited by 2 - Related articles - All 5 versions

HIV-associated multicentric Castleman disease


E Oksenhendler - Current Opinion in HIV and AIDS, 2009 - journals.lww.com
Summary: Etoposide is the most effective first-line therapy for active
multicentric Castleman disease. Rituximab can be used after an initial control
of the attack and provides a 1-year remission rate above 70%. Exacerbation ...
Cited by 1 - Related articles - All 3 versions

New approaches to the treatment of human herpesvirus 8-associated disease


C Casper - Reviews in medical virology, 2008 - pubmedcentral.nih.gov
Human herpesvirus 8 (HHV-8, also known as Kaposi sarcoma-associated herpesvirus
or KSHV) is the etiologic agent of Kaposi sarcoma (KS) and primary effusion
lymphoma (PEL), as well as many cases of Castleman disease. Despite ...
Cited by 1 - Related articles - All 6 versions

FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease


R Barker, F Kazmi, J Stebbing, S Ngan, R … - European Journal of Nuclear Medicine and Molecular …, 2009 - Springer
Abstract Purpose To evaluate the role of FDG-PET/CT scanning in the management
of HIV-associated multicentric Castleman's disease (MCD) a rare
lymphoproliferative disorder associated with infection by human herpesvirus ...
Cited by 1 - Related articles - All 3 versions

The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated …


T Powles, J Stebbing, A Bazeos, E … - Annals of Oncology, 2009 - Eur Soc Med Oncology
Results: From 24 cases of HIV-associated MCD, the incidence measured 4.3/10 000
patient-years [95% confidence interval (CI) 2.7–6.4]. The incidence in the
pre-HAART (1983–1996), early-HAART (1997–2001) and later HAART ...
Cited by 1 - Related articles - All 6 versions

Journal List> J Korean Ophthalmol Soc> v. 50 (5); May 2009


JK Chae, SP Park, TH Choi - J Korean Ophthalmol Soc, 2009 - synapse.koreamed.org
J Korean Ophthalmol Soc. 2009 May;50(5):769-773. Published online 2009 May 20.
doi: 10.3341/jkos.2009.50.5.769. ... 1 Department of Ophthalmology, Seoul
National University College of Medicine, Seoul, Korea.
Related articles - Cached - All 2 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google